Close X
Attorney Spotlight

What colorful method does Claire Miley use to keep up with the latest healthcare regulations as they relate to proposed transactions? Find out more>

Search

Close X

Experience

Search our Experience

Experience Spotlight

On December 1, 2016, Parker Hannifin Corporation and CLARCOR Inc. announced that the companies have entered into a definitive agreement under which Parker will acquire CLARCOR for approximately $4.3 billion in cash, including the assumption of net debt. The transaction has been unanimously approved by the board of directors of each company. Upon closing of the transaction, expected to be completed by or during the first quarter of Parker’s fiscal year 2018, CLARCOR will be combined with Parker’s Filtration Group to form a leading and diverse global filtration business. Bass, Berry & Sims has served CLARCOR as primary corporate and securities counsel for 10 years and served as lead counsel on this transaction. Read more here.

CLARCOR
Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Securities Law Exchange BlogSecurities Law Exchange blog offers insight on the latest legal and regulatory developments affecting publicly traded companies. It focuses on a wide variety of topics including regulation and reporting updates, public company advisory topics, IPO readiness and exchange updates including IPO announcements, M&A trends and deal news.

Read More >

Julia Tamulis

Associate

Julia Tamulis

Associate

Washington, D.C.
(202) 827-2999 TEL
(202) 330-5985 FAX
Washington, D.C.
(202) 827-2999 TEL
(202) 330-5985 FAX

Julia Tamulis focuses her practice on counseling a diverse range of clients on healthcare regulatory and compliance matters. A former attorney-advisor for the Department of Health and Human Services (HHS), Departmental Appeals Board (DAB), the highest level of appeal within HHS, Julia has written more than 100 decisions involving Medicare Part A and Part B coverage and reimbursement claims. Since leaving HHS DAB, Julia’s practice involves addressing complex healthcare regulatory issues in operations, compliance, and healthcare transactions. Julia advises pediatric hospital systems on internal compliance matters, including daily operations issues, privacy incidents, and internal compliance audits. She also works with specialty pharmacy clients to draft and negotiate agreements across the drug supply chain, including distribution and pharmacy services agreements, and provides guidance on healthcare regulatory requirements applicable to pharmacies and pharmaceutical manufacturers.

Drawing on her healthcare regulatory expertise, Julia assists with internal compliance reviews and responding to government investigations, including defending companies facing government scrutiny in False Claims Act (FCA) matters. She has represented clients in the medical device, Medicare Advantage, long-term care, and imaging sectors, as well as senior healthcare executives, before U.S. Attorneys’ Offices and the HHS Office of Inspector General in FCA, Stark Law, and Anti-Kickback Statute enforcement actions.

Julia Tamulis focuses her practice on counseling a diverse range of clients on healthcare regulatory and compliance matters. A former attorney-advisor for the Department of Health and Human Services (HHS), Departmental Appeals Board (DAB), the highest level of appeal within HHS, Julia has written more than 100 decisions involving Medicare Part A and Part B coverage and reimbursement claims. Since leaving HHS DAB, Julia’s practice involves addressing complex healthcare regulatory issues in operations, compliance, and healthcare transactions. Julia advises pediatric hospital systems on internal compliance matters, including daily operations issues, privacy incidents, and internal compliance audits. She also works with specialty pharmacy clients to draft and negotiate agreements across the drug supply chain, including distribution and pharmacy services agreements, and provides guidance on healthcare regulatory requirements applicable to pharmacies and pharmaceutical manufacturers. 

Drawing on her healthcare regulatory expertise, Julia assists with internal compliance reviews and responding to government investigations, including defending companies facing government scrutiny in False Claims Act (FCA) matters. She has represented clients in the medical device, Medicare Advantage, long-term care, and imaging sectors, as well as senior healthcare executives, before U.S. Attorneys' Offices and the HHS Office of Inspector General in FCA, Stark Law, and Anti-Kickback Statute enforcement actions. 

Julia recognizes the challenges her clients face in adapting to a constantly changing regulatory landscape. Her practice involves:

  • Government Enforcement and Compliance – Defending clients in healthcare fraud enforcement matters through internal investigations and advocacy before governmental entities; conducting compliance assessments; assisting with day-to-day operational matters and internal audits; and drafting compliance policies.
  • Contracting, Regulatory and Operational Matters – Advising on complex transactional, operational, and regulatory matters, including licensure issues, contracting for health systems and pharmaceutical companies, and compliance guidance for hospitals.
  • Specialty Pharmacy – Assisting specialty pharmacy clients with contract drafting and negotiation and regulatory guidance.
  • Medicare Reimbursement Appeals – Filing and arguing appeals before the Office of Medicare Hearings and Appeals' Administrative Law Judges and the Medicare Appeals Council related to Part A inpatient short stay reimbursement denials and enrollment matters.

During law school, Julia was a legal intern with HHS's Departmental Appeals Board, Civil Remedies Division, where she wrote summary judgment rulings for appeals involving skilled nursing facilities.

Additionally, in 2009, Julia researched and wrote a section of the main amicus brief for a high profile death penalty case that the Supreme Court reviewed on behalf of Troy Davis, a Georgia death row inmate, under a claim of original writ of habeas corpus. On August 17, 2009, the Supreme Court granted Mr. Davis' habeas petition—the first time the Court had granted an original habeas petition in nearly 50 years.

+ Read More

- Read Less

Memberships

American Health Lawyers Association (AHLA) — Hospitals and Health Systems Practice Group, Leadership Development Program (2015-2016)

Women's White Collar Defense Association

D.C. Bar Association — Health Law Section, Steering Committee Co-Chair (2016-2018); Health Law Section, Steering Committee (2015-2016); Health Law Section, New Practitioners Planning Committee (2014-2017)

News

View More

Representative Experience

View More

Publications

View More

Past Events

View More

Media Mentions

View More

Accolades

Washington, D.C. Super Lawyers "Rising Star" (2016)

The George Washington University Law School — J.B. and Maurice C. Shapiro Public Service Fellowship Recipient

American Intellectual Property Law Association (AIPLA) Quarterly Journal — Editorial Staff Member

University of Oxford — International Human Rights Law Program (2009)

Notice

Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.